Xeris Biopharma Holdings (XERS) FCF Margin (QoQ) (2021 - 2026)
Xeris Biopharma Holdings (XERS) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -290.00 |
| Mar 31, 2026 | -1,148.00 |
| Dec 31, 2025 | -142.00 |
| Sep 30, 2025 | 2,453.00 |
| Jun 30, 2025 | 1,694.00 |
| Mar 31, 2025 | -1,997.00 |
| Dec 31, 2024 | 1,859.00 |
| Sep 30, 2024 | 623.00 |
| Jun 30, 2024 | 2,843.00 |
| Mar 31, 2024 | -6,679.00 |
| Dec 31, 2023 | 4,707.00 |
| Sep 30, 2023 | 592.00 |
| Jun 30, 2023 | 4,258.00 |
| Mar 31, 2023 | -3,011.00 |
| Dec 31, 2022 | 1,109.00 |
| Sep 30, 2022 | 2,171.00 |
| Jun 30, 2022 | 13,787.00 |
| Mar 31, 2022 | -8,362.00 |
| Dec 31, 2021 | 6,875.00 |
| Sep 30, 2021 | 2,038.00 |